Federal medical and biological Agency (FMBA) Russia has developed a treatment regimen for severe coronavirus pneumonia. This is stated in a message published on April 6 on the FMBA website.
“On behalf of the head of Veronika Skvortsova, the Federal medical and biological Agency has developed a treatment regimen for severe coronavirus pneumonia accompanied by respiratory failure, based on the use of a Delta-opioid receptor agonist a synthetic Hexapeptide “Dalargina”, said in a statement.
Dalargin is registered in Russia as a drug for suppressing proteolysis, healing trophic ulcers and protecting organs and tissues (lungs, liver, pancreas). This drug helped reduce the severity of respiratory distress syndrome.
It is noted that this syndrome, as well as the resulting systemic inflammatory reaction, are complications to pneumonia caused by the coronavirus. According to the head of the FMBA Veronika Skvortsova, the Agency begins clinical studies of “Dalargin” in severe coronavirus pneumonia.
“The highly reliable effect of the drug, which prevents the development of acute respiratory distress syndrome in the experiment and allows animals with interstitial pulmonary edema to survive, gives hope for its effectiveness in the most severe forms of new coronavirus infection in humans,” she said on April 6.
The spread of the SARS-CoV-2 coronavirus, which causes COVID-19 disease, began at the end of December last year. The focus of infection was the Chinese city of Wuhan. In a few months, the disease has spread to more than 190 countries around the world. On March 11, who declared a coronavirus pandemic.
In Russia, 954 new cases of coronavirus were registered per day. Thus, the total number of people infected in the country was 6343, 47 people died from the infection. Cases were recorded in 80 regions.
